News
White House Expands TrumpRx with Diabetes and Lung Disease Medications
The White House announced Friday that three new medications will be added to the TrumpRx platform. The drugs, used to treat Type 2 diabetes and lung disease, are part of the administration's effort to lower drug prices.
The White House is adding Jentadueto and Jentadueto XR for Type 2 diabetes, and Striverdi Respimat for COPD to the TrumpRx platform. The administration launched the platform in January as part of President Trump's push to address rising healthcare costs. Jentadueto lists for about $525 but is priced on TrumpRx starting at around $55, according to the White House. The COPD drug is listed at about $35, down from roughly $276. Ben Link, a contributor at 46brooklyn, a nonprofit group that tracks prescription drug prices, said those are significant discounts. The site has faced criticism for its limited scope, with fewer than 60 drugs listed.
Key Facts
- The White House is adding three drugs to the TrumpRx platform.
- The drugs treat Type 2 diabetes and lung disease.
- The drugs are from German drugmaker Boehringer Ingelheim.
- Jentadueto and Jentadueto XR treat Type 2 diabetes.
- Striverdi Respimat treats COPD.
- The diabetes drugs list for about $525 but are priced on TrumpRx starting around $55.
- The COPD drug is listed at about $35, down from roughly $276.
- The TrumpRx prices are still competitive, even with generic options, according to 46brooklyn.